JP7804631B2 - コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 - Google Patents

コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用

Info

Publication number
JP7804631B2
JP7804631B2 JP2023196356A JP2023196356A JP7804631B2 JP 7804631 B2 JP7804631 B2 JP 7804631B2 JP 2023196356 A JP2023196356 A JP 2023196356A JP 2023196356 A JP2023196356 A JP 2023196356A JP 7804631 B2 JP7804631 B2 JP 7804631B2
Authority
JP
Japan
Prior art keywords
kda
polysaccharide
serotype
average molecular
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023196356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024075506A (ja
JP2024075506A5 (cg-RX-API-DMAC7.html
Inventor
シビル アンダーソン アナリサ
ギャラファー ケイトリン
グウ ジャンシン
カネフスキー イシス
キム ジン―ヒュワン
キース モラン ジャスティン
シン サダム
サレンドラン ナヴィーン
Original Assignee
ファイザー・インク
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファイザー・インク filed Critical ファイザー・インク
Publication of JP2024075506A publication Critical patent/JP2024075506A/ja
Publication of JP2024075506A5 publication Critical patent/JP2024075506A5/ja
Application granted granted Critical
Publication of JP7804631B2 publication Critical patent/JP7804631B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
JP2023196356A 2022-11-22 2023-11-20 コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用 Active JP7804631B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022186098 2022-11-22
JP2022186098 2022-11-22

Publications (3)

Publication Number Publication Date
JP2024075506A JP2024075506A (ja) 2024-06-03
JP2024075506A5 JP2024075506A5 (cg-RX-API-DMAC7.html) 2025-07-30
JP7804631B2 true JP7804631B2 (ja) 2026-01-22

Family

ID=91321582

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023196356A Active JP7804631B2 (ja) 2022-11-22 2023-11-20 コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用

Country Status (1)

Country Link
JP (1) JP7804631B2 (cg-RX-API-DMAC7.html)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014111344A1 (en) 2013-01-15 2014-07-24 Novartis Ag Cycloalkyne derivatized saccharides
CN107261130A (zh) 2017-06-29 2017-10-20 云南沃森生物技术股份有限公司 一种用dsc作为活化剂的细菌多糖蛋白结合疫苗的制备方法
WO2017220753A1 (en) 2016-06-22 2017-12-28 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Pneumococcal polysaccharide-protein conjugate composition
JP2019526573A (ja) 2016-09-02 2019-09-19 サノフィ パスツール インコーポレイテッド ナイセリア・メニンギティディスのワクチン
JP2020504760A (ja) 2016-12-30 2020-02-13 ストロバックス・インコーポレイテッドSutrovax, Inc. 非天然アミノ酸とのポリペプチド抗原接合体
US20200054739A1 (en) 2016-12-30 2020-02-20 Sutrovax, Inc. Conjugated vaccines
JP2024522395A (ja) 2021-05-28 2024-06-19 ファイザー・インク コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用
WO2025133971A1 (en) 2023-12-23 2025-06-26 Pfizer Inc. Improved methods for producing bacterial capsular saccharide glycoconjugates

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014111344A1 (en) 2013-01-15 2014-07-24 Novartis Ag Cycloalkyne derivatized saccharides
WO2017220753A1 (en) 2016-06-22 2017-12-28 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Pneumococcal polysaccharide-protein conjugate composition
JP2019526573A (ja) 2016-09-02 2019-09-19 サノフィ パスツール インコーポレイテッド ナイセリア・メニンギティディスのワクチン
JP2020504760A (ja) 2016-12-30 2020-02-13 ストロバックス・インコーポレイテッドSutrovax, Inc. 非天然アミノ酸とのポリペプチド抗原接合体
US20200054739A1 (en) 2016-12-30 2020-02-20 Sutrovax, Inc. Conjugated vaccines
CN107261130A (zh) 2017-06-29 2017-10-20 云南沃森生物技术股份有限公司 一种用dsc作为活化剂的细菌多糖蛋白结合疫苗的制备方法
JP2024522395A (ja) 2021-05-28 2024-06-19 ファイザー・インク コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用
WO2025133971A1 (en) 2023-12-23 2025-06-26 Pfizer Inc. Improved methods for producing bacterial capsular saccharide glycoconjugates

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEN, Yu-Qiu, et al.,Preparing Polysaccharide-Protein Conjugates by Using N,N'-Carbonyldiimidazole as the Activator of Capsule Polysaccharide of Group A Meningococcal,Chinese Journal of Pharmaceutical Biotechnology,2018年,Vol.25, No.1,pp.26-30,DOI 10.19526/j.cnki.1005-8915.20180106
Glycoconjugate Journal,2020年,Vol.37,p.611-622
Vaccine,2013年,Vol.31,p.5623-5626

Also Published As

Publication number Publication date
JP2024075506A (ja) 2024-06-03

Similar Documents

Publication Publication Date Title
JP7714690B2 (ja) コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用
JP7585203B2 (ja) 免疫原性多重ヘテロ抗原多糖-タンパク質コンジュゲートおよびその使用
JP6884145B2 (ja) 肺炎連鎖球菌ワクチンにおいて用いるための免疫原性組成物
KR20170102009A (ko) 폐렴구균 백신에서 사용하기 위한 면역원성 조성물
US20220387576A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
US20250381259A1 (en) Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof
WO2025133971A1 (en) Improved methods for producing bacterial capsular saccharide glycoconjugates
CA3252845A1 (en) PROCESS FOR PRODUCING FERTILIZER FROM A BIOGAS FLOW
RU2837543C2 (ru) Иммуногенные композиции, содержащие конъюгированные капсульные сахаридные антигены, и их применение
RU2854787C2 (ru) Иммуногенные композиции, содержащие конъюгированные капсульные сахаридные антигены, и их применение
JP2024075506A (ja) コンジュゲートさせた莢膜糖抗原を含む免疫原性組成物およびその使用
KR20240087549A (ko) 접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도
KR20240086722A (ko) 접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도
HK40104691A (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN117729933A (zh) 包含缀合的荚膜糖抗原的免疫原性组合物及其用途
EP4661911A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2025186705A2 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
JP2025537898A (ja) コンジュゲートさせた莢膜糖類抗原を含む免疫原性組成物およびその使用
HK40112911A (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250722

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250722

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20250722

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251027

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251027

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260105

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260109

R150 Certificate of patent or registration of utility model

Ref document number: 7804631

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150